메뉴 건너뛰기




Volumn 15, Issue 3, 2014, Pages 353-363

Leukotriene receptor antagonists pranlukast and montelukast for treating asthma

Author keywords

Airway hyperresponsiveness; Bronchodilation; Inflammation; Pulmonary function; Tachyphylaxis

Indexed keywords

ACETYLSALICYLIC ACID; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; CROMOGLYCATE DISODIUM; LEUKOTRIENE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LEUKOTRIENE RECEPTOR STIMULATING AGENT; MONTELUKAST; PEPTIDOLEUKOTRIENE; PRANLUKAST; SALBUTAMOL; SALMETEROL; THEOPHYLLINE;

EID: 84892773672     PISSN: 14656566     EISSN: 17447666     Source Type: Journal    
DOI: 10.1517/14656566.2014.872241     Document Type: Review
Times cited : (32)

References (100)
  • 1
    • 84858304153 scopus 로고    scopus 로고
    • Global asthma prevalence in adults: Findings from the cross-sectional world health survey
    • To T, Stanojevic S, Moores G, et al. Global asthma prevalence in adults: findings from the cross-sectional world health survey. BMC Public Health 2012;12:204
    • (2012) BMC Public Health , vol.12 , pp. 204
    • To, T.1    Stanojevic, S.2    Moores, G.3
  • 3
    • 0032749366 scopus 로고    scopus 로고
    • Airway remodeling in asthma
    • Elias JA, Zhu Z, Chupp G, et al. Airway remodeling in asthma. J Clin Invest 1999;104:1001-6.
    • (1999) J Clin Invest , vol.104 , pp. 1001-1006
    • Elias, J.A.1    Zhu, Z.2    Chupp, G.3
  • 4
    • 0034113824 scopus 로고    scopus 로고
    • Asthma: From bronchoconstriction to airways inflammation and remodeling
    • Bousquet J, Jeffery PK, Busse WB, et al. Asthma: from bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med 2000;161:1720-45
    • (2000) Am J Respir Crit Care Med , vol.161 , pp. 1720-1745
    • Bousquet, J.1    Jeffery, P.K.2    Busse, W.B.3
  • 5
    • 11144358047 scopus 로고    scopus 로고
    • Hyperplasia of smooth muscle in mild/moderate asthma without changes in cell size or gene expression
    • Woodruff PG, Dolganov GM, Ferrando RE, et al. Hyperplasia of smooth muscle in mild/moderate asthma without changes in cell size or gene expression. Am J Respir Crit Care Med 2004;169:1001-6
    • (2004) Am J Respir Crit Care Med , vol.169 , pp. 1001-1006
    • Woodruff, P.G.1    Dolganov, G.M.2    Ferrando, R.E.3
  • 6
    • 60549087960 scopus 로고    scopus 로고
    • Incremental direct expenditure of treating asthma in the United States
    • Kamble S, Bharmal M. Incremental direct expenditure of treating asthma in the United States. J Asthma 2009;46:73-80
    • (2009) J Asthma , vol.46 , pp. 73-80
    • Kamble, S.1    Bharmal, M.2
  • 7
    • 2542465414 scopus 로고    scopus 로고
    • European Lung Foundation European Respiratory Society; Geneva
    • European Lung Foundation. European lung white book. European Respiratory Society; Geneva: 2003
    • (2003) European Lung White Book
  • 9
    • 84944495461 scopus 로고
    • The release of histamine and formation of a slow-reacting substance (SRS-A) during anaphylactic shock
    • Brocklehurst WE. The release of histamine and formation of a slow-reacting substance (SRS-A) during anaphylactic shock. J Physiol 1960;151:416-35
    • (1960) J Physiol , vol.151 , pp. 416-435
    • Brocklehurst, W.E.1
  • 12
    • 69349105178 scopus 로고    scopus 로고
    • The leukotriene E4 puzzle: Finding the missing pieces and revealing the pathobiologic implications
    • quiz 415-6
    • Austen KF, Maekawa A, Kanaoka Y, Boyce JA. The leukotriene E4 puzzle: finding the missing pieces and revealing the pathobiologic implications. J Allergy Clin Immunol 2009;124:406-14; quiz 415-6
    • (2009) J Allergy Clin Immunol , vol.124 , pp. 406-414
    • Austen, K.F.1    Maekawa, A.2    Kanaoka, Y.3    Boyce, J.A.4
  • 13
    • 0028694621 scopus 로고
    • Release of urinary leukotriene E4 in asthmatic subjects: A review
    • In: Dahlen S-E, Hedqvist P, Samuelsson B, Taylor WA, Fritsch J, editors Raven Press; New York
    • Taylor IK. Release of urinary leukotriene E4 in asthmatic subjects: a review. In: Dahlen S-E, Hedqvist P, Samuelsson B, Taylor WA, Fritsch J, editors. Advances in prostaglandin, thromboxane, and leukotriene research. Raven Press; New York: 1994. p. 167-83
    • (1994) Advances in Prostaglandin, Thromboxane, and Leukotriene Research , pp. 167-183
    • Taylor, I.K.1
  • 14
    • 0026644731 scopus 로고
    • Urinary excretion of leukotriene E4 and 11-dehydro-thromboxane B2 in response to bronchial provocations with allergen, aspirin, leukotriene D4, and histamine in asthmatics
    • Kumlin M, Dahlén B, Bjorck T, et al. Urinary excretion of leukotriene E4 and 11-dehydro-thromboxane B2 in response to bronchial provocations with allergen, aspirin, leukotriene D4, and histamine in asthmatics. Am Rev Respir Dis 1992;146:96-103
    • (1992) Am Rev Respir Dis , vol.146 , pp. 96-103
    • Kumlin, M.1    Dahlén, B.2    Bjorck, T.3
  • 15
    • 0032725747 scopus 로고    scopus 로고
    • Anti-inflammatory mechanisms of leukotriene modulators
    • Diamant Z, Sampson AP. Anti-inflammatory mechanisms of leukotriene modulators. Clin Exp Allergy 1999;29:1449-53
    • (1999) Clin Exp Allergy , vol.29 , pp. 1449-1453
    • Diamant, Z.1    Sampson, A.P.2
  • 16
    • 0041528459 scopus 로고    scopus 로고
    • Cysteinyl leukotrienes induce NF-kappaB activation and RANTES production in a murine model of allergic asthma
    • Kawano T, Matsuse H, Kondo Y, et al. Cysteinyl leukotrienes induce NF-kappaB activation and RANTES production in a murine model of allergic asthma. J Allergy Clin Immunol 2003;112:369-74
    • (2003) J Allergy Clin Immunol , vol.112 , pp. 369-374
    • Kawano, T.1    Matsuse, H.2    Kondo, Y.3
  • 17
  • 18
    • 0031943061 scopus 로고    scopus 로고
    • Effect of synthetase inhibitors and receptor antagonists in antigen-induced contraction of human lung parenchyma
    • Fukushima C, Shimoda T, Matsuse H, et al. Effect of synthetase inhibitors and receptor antagonists in antigen-induced contraction of human lung parenchyma. Ann Allergy Asthma Immunol 1998;80:245-50
    • (1998) Ann Allergy Asthma Immunol , vol.80 , pp. 245-250
    • Fukushima, C.1    Shimoda, T.2    Matsuse, H.3
  • 19
    • 20144378092 scopus 로고    scopus 로고
    • Pranlukast, a leukotriene receptor antagonist, inhibits interleukin-5 production via a mechanism distinct from leukotriene receptor antagonism
    • Fukushima C, Matsuse H, Hishikawa Y, et al. Pranlukast, a leukotriene receptor antagonist, inhibits interleukin-5 production via a mechanism distinct from leukotriene receptor antagonism. Int Arch Allergy Immunol 2005;136:165-72
    • (2005) Int Arch Allergy Immunol , vol.136 , pp. 165-172
    • Fukushima, C.1    Matsuse, H.2    Hishikawa, Y.3
  • 20
    • 0037699908 scopus 로고    scopus 로고
    • Pranlukast, a cysteinyl leukotriene receptor 1 antagonist, attenuates allergen specific TNF-alpha production and NF-kappaB nuclear translocation in peripheral blood monocytes from atopic asthmatics
    • Tomari S, Matsuse H, Machida I, et al. Pranlukast, a cysteinyl leukotriene receptor 1 antagonist, attenuates allergen specific TNF-alpha production and NF-kappaB nuclear translocation in peripheral blood monocytes from atopic asthmatics. Clin Exp Allergy 2003;33:795-801
    • (2003) Clin Exp Allergy , vol.33 , pp. 795-801
    • Tomari, S.1    Matsuse, H.2    Machida, I.3
  • 21
    • 0032496618 scopus 로고    scopus 로고
    • Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma: A multicenter, randomized, double-blind trial
    • Reiss TF, Chervinsky P, Dockhorn RJ, et al. Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma: a multicenter, randomized, double-blind trial. Arch Intern Med 1998;158:1213-20
    • (1998) Arch Intern Med , vol.158 , pp. 1213-1220
    • Reiss, T.F.1    Chervinsky, P.2    Dockhorn, R.J.3
  • 22
    • 33749435086 scopus 로고    scopus 로고
    • Improvements in distal lung function correlate with asthma symptoms after treatment with oral montelukast
    • Kraft M, Cairns CB, Ellison MC, et al. Improvements in distal lung function correlate with asthma symptoms after treatment with oral montelukast. Chest 2006;130:1726-32
    • (2006) Chest , vol.130 , pp. 1726-1732
    • Kraft, M.1    Cairns, C.B.2    Ellison, M.C.3
  • 23
    • 0037460848 scopus 로고    scopus 로고
    • Inhaled glucocorticoids versus leukotriene receptor antagonists as single agent asthma treatment: Systematic review of current evidence
    • Ducharme FM. Inhaled glucocorticoids versus leukotriene receptor antagonists as single agent asthma treatment: systematic review of current evidence. BMJ 2003;326:621
    • (2003) BMJ , vol.326 , pp. 621
    • Ducharme, F.M.1
  • 24
    • 0037249234 scopus 로고    scopus 로고
    • Cysteinyl leukotriene interactions with other mediators and with glucocorticosteroids during airway inflammation
    • discussion S43-8
    • Peters-Golden M, Sampson AP. Cysteinyl leukotriene interactions with other mediators and with glucocorticosteroids during airway inflammation. J Allergy Clin Immunol 2003;111:S37-42; discussion S43-8
    • (2003) J Allergy Clin Immunol , vol.111
    • Peters-Golden, M.1    Sampson, A.P.2
  • 25
    • 0034857142 scopus 로고    scopus 로고
    • Effects of pranlukast, a cysteinyl leukotriene receptor 1 antagonist, combined with inhaled beclomethasone in patients with moderate or severe asthma
    • Tomari S, Shimoda T, Kawano T, et al. Effects of pranlukast, a cysteinyl leukotriene receptor 1 antagonist, combined with inhaled beclomethasone in patients with moderate or severe asthma. Ann Allergy Asthma Immunol 2001;87:156-61
    • (2001) Ann Allergy Asthma Immunol , vol.87 , pp. 156-161
    • Tomari, S.1    Shimoda, T.2    Kawano, T.3
  • 26
    • 0037338743 scopus 로고    scopus 로고
    • Randomised controlled trial of montelukast plus inhaled budesonide versus double dose inhaled budesonide in adult patients with asthma
    • Price DB, Hernandez D, Magyar P, et al. Randomised controlled trial of montelukast plus inhaled budesonide versus double dose inhaled budesonide in adult patients with asthma. Thorax 2003;58:211-16
    • (2003) Thorax , vol.58 , pp. 211-216
    • Price, D.B.1    Hernandez, D.2    Magyar, P.3
  • 27
    • 25644440589 scopus 로고    scopus 로고
    • Evaluation of theophylline or pranlukast, a cysteinyl leukotriene receptor 1 antagonist, as add-on therapy in uncontrolled asthmatic patients with a medium dose of inhaled corticosteroids
    • Tsuchida T, Matsuse H, Machida I, et al. Evaluation of theophylline or pranlukast, a cysteinyl leukotriene receptor 1 antagonist, as add-on therapy in uncontrolled asthmatic patients with a medium dose of inhaled corticosteroids. Allergy Asthma Proc 2005;26:287-91
    • (2005) Allergy Asthma Proc , vol.26 , pp. 287-291
    • Tsuchida, T.1    Matsuse, H.2    Machida, I.3
  • 28
    • 0034538067 scopus 로고    scopus 로고
    • Fluticasone propionate/salmeterol combination provides more effective asthma control than low-dose inhaled corticosteroid plus montelukast
    • Nelson HS, Busse WW, Kerwin E, et al. Fluticasone propionate/salmeterol combination provides more effective asthma control than low-dose inhaled corticosteroid plus montelukast. J Allergy Clin Immunol 2000;106:1088-95
    • (2000) J Allergy Clin Immunol , vol.106 , pp. 1088-1095
    • Nelson, H.S.1    Busse, W.W.2    Kerwin, E.3
  • 29
    • 0034821077 scopus 로고    scopus 로고
    • Salmeterol powder provides significantly better benefit than montelukast in asthmatic patients receiving concomitant inhaled corticosteroid therapy
    • Fish JE, Israel E, Murray JJ, et al. Salmeterol powder provides significantly better benefit than montelukast in asthmatic patients receiving concomitant inhaled corticosteroid therapy. Chest 2001;120:423-30
    • (2001) Chest , vol.120 , pp. 423-430
    • Fish, J.E.1    Israel, E.2    Murray, J.J.3
  • 30
    • 0037372118 scopus 로고    scopus 로고
    • The salmeterol/fluticasone combination is more effective than fluticasone plus oral montelukast in asthma
    • Ringdal N, Eliraz A, Pruzinec R, et al. The salmeterol/fluticasone combination is more effective than fluticasone plus oral montelukast in asthma. Respir Med 2003;97:234-41
    • (2003) Respir Med , vol.97 , pp. 234-241
    • Ringdal, N.1    Eliraz, A.2    Pruzinec, R.3
  • 31
    • 3242808287 scopus 로고    scopus 로고
    • Addition of montelukast or salmeterol to fluticasone for protection against asthma attacks: A randomized, double-blind, multicenter study
    • Ilowite J, Webb R, Friedman B, et al. Addition of montelukast or salmeterol to fluticasone for protection against asthma attacks: a randomized, double-blind, multicenter study. Ann Allergy Asthma Immunol 2004;92:641-8
    • (2004) Ann Allergy Asthma Immunol , vol.92 , pp. 641-648
    • Ilowite, J.1    Webb, R.2    Friedman, B.3
  • 32
    • 79955716906 scopus 로고    scopus 로고
    • Leukotriene antagonists as first-line or add-on asthma-controller therapy
    • Price D, Musgrave SD, Shepstone L, et al. Leukotriene antagonists as first-line or add-on asthma-controller therapy. N Engl J Med 2011;364:1695-707.
    • (2011) N Engl J Med , vol.364 , pp. 1695-1707
    • Price, D.1    Musgrave, S.D.2    Shepstone, L.3
  • 33
    • 0038555464 scopus 로고    scopus 로고
    • Effects of montelukast on surrogate inflammatory markers in corticosteroidtreated patients with asthma
    • Currie GP, Lee DK, Haggart K, et al. Effects of montelukast on surrogate inflammatory markers in corticosteroidtreated patients with asthma. Am J Respir Crit Care Med 2003;167:1232-8
    • (2003) Am J Respir Crit Care Med , vol.167 , pp. 1232-1238
    • Currie, G.P.1    Lee, D.K.2    Haggart, K.3
  • 34
    • 64249140278 scopus 로고    scopus 로고
    • Efficacy of add-on montelukast in patients with non-controlled asthma: A Belgian open-label study
    • Korn D, Van den Brande P, Potvin E, et al. Efficacy of add-on montelukast in patients with non-controlled asthma: a Belgian open-label study. Curr Med Res Opin 2009;25:489-97
    • (2009) Curr Med Res Opin , vol.25 , pp. 489-497
    • Korn, D.1    Van Den Brande, P.2    Potvin, E.3
  • 35
    • 56649094467 scopus 로고    scopus 로고
    • Observational study of the additive effects of pranlukast on inflammatory markers of clinically stable asthma with inhaled corticosteroids and long-acting beta 2 agonists
    • Tomari S, Matsuse H, Hirose H, et al. Observational study of the additive effects of pranlukast on inflammatory markers of clinically stable asthma with inhaled corticosteroids and long-acting beta 2 agonists. Respiration 2008;76:398-402
    • (2008) Respiration , vol.76 , pp. 398-402
    • Tomari, S.1    Matsuse, H.2    Hirose, H.3
  • 36
    • 16244392063 scopus 로고    scopus 로고
    • Exhaled breath condensate cysteinyl leukotrienes are increased in children with exercise-induced bronchoconstriction
    • Carraro S, Corradi M, Zanconato S, et al. Exhaled breath condensate cysteinyl leukotrienes are increased in children with exercise-induced bronchoconstriction. J Allergy Clin Immunol 2005;115:764-70
    • (2005) J Allergy Clin Immunol , vol.115 , pp. 764-770
    • Carraro, S.1    Corradi, M.2    Zanconato, S.3
  • 37
    • 84876493130 scopus 로고    scopus 로고
    • Ratio of leukotriene E4 to exhaled nitric oxide and the therapeutic response in children with exercise-induced bronchoconstriction
    • Baek HS, Cho J, Kim JH, et al. Ratio of leukotriene E4 to exhaled nitric oxide and the therapeutic response in children with exercise-induced bronchoconstriction. Allergy Asthma Immunol Res 2013;5:26-33
    • (2013) Allergy Asthma Immunol Res , vol.5 , pp. 26-33
    • Baek, H.S.1    Cho, J.2    Kim, J.H.3
  • 38
    • 0033982571 scopus 로고    scopus 로고
    • Oral montelukast compared with inhaled salmeterol to prevent exerciseinduced bronchoconstriction: A randomized, double-blind trial
    • Edelman JM, Turpin JA, Bronsky EA, et al. Oral montelukast compared with inhaled salmeterol to prevent exerciseinduced bronchoconstriction: a randomized, double-blind trial. Ann Intern Med 2000;132:97-104
    • (2000) Ann Intern Med , vol.132 , pp. 97-104
    • Edelman, J.M.1    Turpin, J.A.2    Bronsky, E.A.3
  • 39
    • 0025892285 scopus 로고
    • Urinary leukotriene E4 concentrations increase after aspirin challenge in aspirin-sensitive asthmatic subjects
    • Christie PE, Tagari P, Ford-Hutchinson AW, et al. Urinary leukotriene E4 concentrations increase after aspirin challenge in aspirin-sensitive asthmatic subjects. Am Rev Respir Dis 1991;143:1025-9
    • (1991) Am Rev Respir Dis , vol.143 , pp. 1025-1029
    • Christie, P.E.1    Tagari, P.2    Ford-Hutchinson, A.W.3
  • 40
    • 0036142418 scopus 로고    scopus 로고
    • Improvement of aspirin-intolerant asthma by montelukast a leukotriene antagonist: A randomized double-blind placebo-controlled trial
    • Dahlén SE, Malmstrom K, Nizankowska E, et al. Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trial. Am J Respir Crit Care Med 2002;165:9-14
    • (2002) Am J Respir Crit Care Med , vol.165 , pp. 9-14
    • Dahlén, S.E.1    Malmstrom, K.2    Nizankowska, E.3
  • 41
    • 0034905786 scopus 로고    scopus 로고
    • Effects of pranlukast on aspirin-induced bronchoconstriction: Differences in chemical mediators between aspirinintolerant and tolerant asthmatic patients
    • Obase Y, Shimoda T, Tomari S, et al. Effects of pranlukast on aspirin-induced bronchoconstriction: differences in chemical mediators between aspirinintolerant and tolerant asthmatic patients. Ann Allergy Asthma Immunol 2001;87:74-9
    • (2001) Ann Allergy Asthma Immunol , vol.87 , pp. 74-79
    • Obase, Y.1    Shimoda, T.2    Tomari, S.3
  • 42
    • 0036155106 scopus 로고    scopus 로고
    • Effects of pranlukast on chemical mediators in induced sputum on provocation tests in atopic and aspirinintolerant asthmatic patients
    • Obase Y, Shimoda T, Tomari SY, et al. Effects of pranlukast on chemical mediators in induced sputum on provocation tests in atopic and aspirinintolerant asthmatic patients. Chest 2002;121:143-50
    • (2002) Chest , vol.121 , pp. 143-150
    • Obase, Y.1    Shimoda, T.2    Tomari, S.Y.3
  • 43
    • 84873964719 scopus 로고    scopus 로고
    • Menstrual cycle and respiratory symptoms in a general Nordic-Baltic population
    • Macsali F, Svanes C, Sothern RB, et al. Menstrual cycle and respiratory symptoms in a general Nordic-Baltic population. Am J Respir Crit Care Med 2013;187:366-73
    • (2013) Am J Respir Crit Care Med , vol.187 , pp. 366-373
    • MacSali, F.1    Svanes, C.2    Sothern, R.B.3
  • 44
    • 34548849742 scopus 로고    scopus 로고
    • Analysis of perimenstrual asthma based on questionnaire surveys in Japan
    • Suzuki K, Hasegawa T, Sakagami T, et al. Analysis of perimenstrual asthma based on questionnaire surveys in Japan. Allergol Int 2007;56:249-55
    • (2007) Allergol Int , vol.56 , pp. 249-255
    • Suzuki, K.1    Hasegawa, T.2    Sakagami, T.3
  • 45
    • 84876012788 scopus 로고    scopus 로고
    • Characteristics of perimenstrual asthma and its relation to asthma severity and control. Data from the Severe Asthma Research Program
    • Rao CK, Moore CG, Bleecker E, et al. Characteristics of perimenstrual asthma and its relation to asthma severity and control. Data from the Severe Asthma Research Program. Chest 2013;143:984-92
    • (2013) Chest , vol.143 , pp. 984-992
    • Rao, C.K.1    Moore, C.G.2    Bleecker, E.3
  • 46
    • 0032825340 scopus 로고    scopus 로고
    • Prevention of severe premenstrual asthma attacks by leukotriene receptor antagonist
    • Nakasato H, Ohrui T, Sekizawa K, et al. Prevention of severe premenstrual asthma attacks by leukotriene receptor antagonist. J Allergy Clin Immunol 1999;104:585-8
    • (1999) J Allergy Clin Immunol , vol.104 , pp. 585-588
    • Nakasato, H.1    Ohrui, T.2    Sekizawa, K.3
  • 47
    • 40949109384 scopus 로고    scopus 로고
    • Leukotriene receptor antagonists: A good choice in the treatment of premenstrual asthma?
    • Pasaoglu G, Mungan D, Abadoglu O, Misirligil Z. Leukotriene receptor antagonists: a good choice in the treatment of premenstrual asthma? J Asthma 2008;45:95-9
    • (2008) J Asthma , vol.45 , pp. 95-99
    • Pasaoglu, G.1    Mungan, D.2    Abadoglu, O.3    Misirligil, Z.4
  • 48
    • 84859159409 scopus 로고    scopus 로고
    • Clinical, physiological and antiinflammatory effect of montelukast in patients with cough variant asthma
    • Takemura M, Niimi A, Matsumoto H, et al. Clinical, physiological and antiinflammatory effect of montelukast in patients with cough variant asthma. Respiration 2012;83:308-15
    • (2012) Respiration , vol.83 , pp. 308-315
    • Takemura, M.1    Niimi, A.2    Matsumoto, H.3
  • 49
    • 77958101727 scopus 로고    scopus 로고
    • Comparable effect of a leukotriene receptor antagonist and long-acting beta-adrenergic agonist in cough variant asthma
    • Tamaoki J, Yokohori N, Tagaya E, et al. Comparable effect of a leukotriene receptor antagonist and long-acting beta-adrenergic agonist in cough variant asthma. Allergy Asthma Proc 2010;31:78-84
    • (2010) Allergy Asthma Proc , vol.31 , pp. 78-84
    • Tamaoki, J.1    Yokohori, N.2    Tagaya, E.3
  • 50
    • 21844431891 scopus 로고    scopus 로고
    • Increased risk of asthma attacks and emergency visits among asthma patients with allergic rhinitis: A subgroup analysis of the investigation of montelukast as a partner agent for complementary therapy
    • Bousquet J, Gaugris S, Kocevar VS, et al. Increased risk of asthma attacks and emergency visits among asthma patients with allergic rhinitis: a subgroup analysis of the investigation of montelukast as a partner agent for complementary therapy. Clin Exp Allergy 2005;35:723-7
    • (2005) Clin Exp Allergy , vol.35 , pp. 723-727
    • Bousquet, J.1    Gaugris, S.2    Kocevar, V.S.3
  • 51
    • 55249101550 scopus 로고    scopus 로고
    • Intranasal corticosteroid administration reduces nonspecific bronchial hyperresponsiveness and improves asthma symptoms
    • Agondi RC, Machado ML, Kalil J, Giavina-Bianchi P. Intranasal corticosteroid administration reduces nonspecific bronchial hyperresponsiveness and improves asthma symptoms. J Asthma 2008;45:754-7
    • (2008) J Asthma , vol.45 , pp. 754-757
    • Agondi, R.C.1    MacHado, M.L.2    Kalil, J.3    Giavina-Bianchi, P.4
  • 52
    • 33744461567 scopus 로고    scopus 로고
    • Effect of montelukast on lung function in asthma patients with allergic rhinitis: Analysis from the COMPACT trial
    • Price DB, Swern A, Tozzi CA, et al. Effect of montelukast on lung function in asthma patients with allergic rhinitis: analysis from the COMPACT trial. Allergy 2006;61:737-42
    • (2006) Allergy , vol.61 , pp. 737-742
    • Price, D.B.1    Swern, A.2    Tozzi, C.A.3
  • 53
    • 77956378655 scopus 로고    scopus 로고
    • Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision
    • Brozek JL, Bousquet J, Baena-Cagnani CE, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision. J Allergy Clin Immunol 2010;126:466-76.
    • (2010) J Allergy Clin Immunol , vol.126 , pp. 466-476
    • Brozek, J.L.1    Bousquet, J.2    Baena-Cagnani, C.E.3
  • 54
    • 0029912952 scopus 로고    scopus 로고
    • Oral prednisone therapy in experimental rhinovirus infections
    • Gustafson LM, Proud D, Hendley JO, et al. Oral prednisone therapy in experimental rhinovirus infections. J Allergy Clin Immunol 1996;97:1009-14
    • (1996) J Allergy Clin Immunol , vol.97 , pp. 1009-1014
    • Gustafson, L.M.1    Proud, D.2    Hendley, J.O.3
  • 55
    • 84887020404 scopus 로고    scopus 로고
    • Rhinovirus infection causes steroid resistance in airway epithelium through nuclear factor kappaB and c-Jun Nterminal kinase activation
    • Epub ahead of print
    • Papi A, Contoli M, Adcock IM, et al. Rhinovirus infection causes steroid resistance in airway epithelium through nuclear factor kappaB and c-Jun Nterminal kinase activation. J Allergy Clin Immunol 2013; Epub ahead of print
    • (2013) J Allergy Clin Immunol
    • Papi, A.1    Contoli, M.2    Adcock, I.M.3
  • 56
    • 33750728633 scopus 로고    scopus 로고
    • Respiratory syncytial virus infection reduces beta2-adrenergic responses in human airway smooth muscle
    • Moore PE, Cunningham G, Calder MM, et al. Respiratory syncytial virus infection reduces beta2-adrenergic responses in human airway smooth muscle. Am J Respir Cell Mol Biol 2006;35:559-64
    • (2006) Am J Respir Cell Mol Biol , vol.35 , pp. 559-564
    • Moore, P.E.1    Cunningham, G.2    Calder, M.M.3
  • 57
    • 0032578912 scopus 로고    scopus 로고
    • Respiratory syncytial virus induces the expression of 5-lipoxygenase and endothelin-1 in bronchial epithelial cells
    • Behera AK, Kumar M, Matsuse H, et al. Respiratory syncytial virus induces the expression of 5-lipoxygenase and endothelin-1 in bronchial epithelial cells. Biochem Biophys Res Commun 1998;251:704-9
    • (1998) Biochem Biophys Res Commun , vol.251 , pp. 704-709
    • Behera, A.K.1    Kumar, M.2    Matsuse, H.3
  • 58
    • 27544507363 scopus 로고    scopus 로고
    • Naturally occurring parainfluenza virus 3 infection in adults induces mild exacerbation of asthma associated with increased sputum concentrations of cysteinyl leukotrienes
    • Matsuse H, Kondo Y, Saeki S, et al. Naturally occurring parainfluenza virus 3 infection in adults induces mild exacerbation of asthma associated with increased sputum concentrations of cysteinyl leukotrienes. Int Arch Allergy Immunol 2005;138:267-72
    • (2005) Int Arch Allergy Immunol , vol.138 , pp. 267-272
    • Matsuse, H.1    Kondo, Y.2    Saeki, S.3
  • 59
    • 84877871499 scopus 로고    scopus 로고
    • Differential airway inflammatory responses in asthma exacerbations induced by respiratory syncytial virus and influenza virus A
    • Matsuse H, Tsuchida T, Fukahori S, et al. Differential airway inflammatory responses in asthma exacerbations induced by respiratory syncytial virus and influenza virus A. Int Arch Allergy Immunol 2013;161:378-82
    • (2013) Int Arch Allergy Immunol , vol.161 , pp. 378-382
    • Matsuse, H.1    Tsuchida, T.2    Fukahori, S.3
  • 60
    • 28644446476 scopus 로고    scopus 로고
    • Localization and upregulation of cysteinyl leukotriene-1 receptor in asthmatic bronchial mucosa
    • Zhu J, Qiu YS, Figueroa DJ, et al. Localization and upregulation of cysteinyl leukotriene-1 receptor in asthmatic bronchial mucosa. Am J Respir Cell Mol Biol 2005;33:531-40
    • (2005) Am J Respir Cell Mol Biol , vol.33 , pp. 531-540
    • Zhu, J.1    Qiu, Y.S.2    Figueroa, D.J.3
  • 61
    • 84892688395 scopus 로고    scopus 로고
    • Regulation of dendritic cell functions against harmful pathogens by a leukotriene receptor antagonist
    • Matsuse H, Hirose H, Fukahori S, et al. Regulation of dendritic cell functions against harmful pathogens by a leukotriene receptor antagonist. Allergy Rhinol 2012;3:e30-4
    • (2012) Allergy Rhinol , vol.3
    • Matsuse, H.1    Hirose, H.2    Fukahori, S.3
  • 62
    • 84863971651 scopus 로고    scopus 로고
    • Effects of a short-course of pranlukast in combination with systemic corticosteroid on acute asthma exacerbation induced by upper respiratory tract infection
    • Matsuse H, Fukahori S, Tsuchida T, et al. Effects of a short-course of pranlukast in combination with systemic corticosteroid on acute asthma exacerbation induced by upper respiratory tract infection. J Asthma 2012;49:637-41
    • (2012) J Asthma , vol.49 , pp. 637-641
    • Matsuse, H.1    Fukahori, S.2    Tsuchida, T.3
  • 63
    • 13544276896 scopus 로고    scopus 로고
    • Montelukast reduces asthma exacerbations in 2-to 5-year-old children with intermittent asthma
    • Bisgaard H, Zielen S, Garcia-Garcia ML, et al. Montelukast reduces asthma exacerbations in 2-to 5-year-old children with intermittent asthma. Am J Respir Crit Care Med 2005;171:315-22
    • (2005) Am J Respir Crit Care Med , vol.171 , pp. 315-322
    • Bisgaard, H.1    Zielen, S.2    Garcia-Garcia, M.L.3
  • 64
    • 42749090393 scopus 로고    scopus 로고
    • Obesity and asthma: Possible mechanisms
    • A review of the interaction between obesity and asthma
    • Shore SA. Obesity and asthma: possible mechanisms. J Allergy Clin Immunol 2008;121:1087-93. A review of the interaction between obesity and asthma.
    • (2008) J Allergy Clin Immunol , vol.121 , pp. 1087-1093
    • Shore, S.A.1
  • 66
    • 78650052167 scopus 로고    scopus 로고
    • Body mass index is associated with leukotriene inflammation in asthmatics
    • Giouleka P, Papatheodorou G, Lyberopoulos P, et al. Body mass index is associated with leukotriene inflammation in asthmatics. Eur J Clin Invest 2011;41:30-8
    • (2011) Eur J Clin Invest , vol.41 , pp. 30-38
    • Giouleka, P.1    Papatheodorou, G.2    Lyberopoulos, P.3
  • 67
    • 33644865225 scopus 로고    scopus 로고
    • Influence of body mass index on the response to asthma controller agents
    • Peters-Golden M, Swern A, Bird SS, et al. Influence of body mass index on the response to asthma controller agents. Eur Respir J 2006;27:495-503
    • (2006) Eur Respir J , vol.27 , pp. 495-503
    • Peters-Golden, M.1    Swern, A.2    Bird, S.S.3
  • 69
    • 0031042693 scopus 로고    scopus 로고
    • Cigarette smoking stimulates cysteinyl leukotriene production in man
    • Fauler J, Frolich JC. Cigarette smoking stimulates cysteinyl leukotriene production in man. Eur J Clin Invest 1997;27:43-7
    • (1997) Eur J Clin Invest , vol.27 , pp. 43-47
    • Fauler, J.1    Frolich, J.C.2
  • 70
    • 34247344095 scopus 로고    scopus 로고
    • Smoking affects response to inhaled corticosteroids or leukotriene receptor antagonists in asthma
    • Lazarus SC, Chinchilli VM, Rollings NJ, et al. Smoking affects response to inhaled corticosteroids or leukotriene receptor antagonists in asthma. Am J Respir Crit Care Med 2007;175:783-90
    • (2007) Am J Respir Crit Care Med , vol.175 , pp. 783-790
    • Lazarus, S.C.1    Chinchilli, V.M.2    Rollings, N.J.3
  • 71
    • 84875220579 scopus 로고    scopus 로고
    • Effect of montelukast for treatment of asthma in cigarette smokers
    • Price D, Popov TA, Bjermer L, et al. Effect of montelukast for treatment of asthma in cigarette smokers. J Allergy Clin Immunol 2013;131:763-71
    • (2013) J Allergy Clin Immunol , vol.131 , pp. 763-771
    • Price, D.1    Popov, T.A.2    Bjermer, L.3
  • 73
    • 84862862358 scopus 로고    scopus 로고
    • Montelukast as an add-on therapy to inhaled corticosteroids in the treatment of severe asthma in elderly patients
    • Bozek A, Warkocka-Szoltysek B, Filipowska-Gronska A, Jarzab J. Montelukast as an add-on therapy to inhaled corticosteroids in the treatment of severe asthma in elderly patients. J Asthma 2012;49:530-4
    • (2012) J Asthma , vol.49 , pp. 530-534
    • Bozek, A.1    Warkocka-Szoltysek, B.2    Filipowska-Gronska, A.3    Jarzab, J.4
  • 74
    • 58149398605 scopus 로고    scopus 로고
    • ERK-mediated regulation of leukotriene biosynthesis by androgens: A molecular basis for gender differences in inflammation and asthma
    • The study demonstrates the gender differences in LT production
    • Pergola C, Dodt G, Rossi A, et al. ERK-mediated regulation of leukotriene biosynthesis by androgens: a molecular basis for gender differences in inflammation and asthma. Proc Natl Acad Sci USA 2008;105:19881-6. The study demonstrates the gender differences in LT production.
    • (2008) Proc Natl Acad Sci USA , vol.105 , pp. 19881-19886
    • Pergola, C.1    Dodt, G.2    Rossi, A.3
  • 75
    • 44649161234 scopus 로고    scopus 로고
    • Exposure to tobacco smoke increases leukotriene E4-related albuterol usage and response to montelukast
    • Rabinovitch N, Strand M, Stuhlman K, Gelfand EW. Exposure to tobacco smoke increases leukotriene E4-related albuterol usage and response to montelukast. J Allergy Clin Immunol 2008;121:1365-71
    • (2008) J Allergy Clin Immunol , vol.121 , pp. 1365-1371
    • Rabinovitch, N.1    Strand, M.2    Stuhlman, K.3    Gelfand, E.W.4
  • 76
    • 83155173901 scopus 로고    scopus 로고
    • Appraising the small airways in asthma
    • Johnson JR, Hamid Q. Appraising the small airways in asthma. Curr Opin Pulm Med 2012;18:23-8
    • (2012) Curr Opin Pulm Med , vol.18 , pp. 23-28
    • Johnson, J.R.1    Hamid, Q.2
  • 77
    • 84864003920 scopus 로고    scopus 로고
    • Do small airway abnormalities characterize asthma phenotypes? in search of proof
    • Contoli M, Kraft M, Hamid Q, et al. Do small airway abnormalities characterize asthma phenotypes? In search of proof. Clin Exp Allergy 2012;42:1150-60
    • (2012) Clin Exp Allergy , vol.42 , pp. 1150-1160
    • Contoli, M.1    Kraft, M.2    Hamid, Q.3
  • 78
    • 0031817795 scopus 로고    scopus 로고
    • Inflammatory cell distribution within and along asthmatic airways
    • Haley KJ, Sunday ME, Wiggs BR, et al. Inflammatory cell distribution within and along asthmatic airways. Am J Respir Crit Care Med 1998;158:565-72
    • (1998) Am J Respir Crit Care Med , vol.158 , pp. 565-572
    • Haley, K.J.1    Sunday, M.E.2    Wiggs, B.R.3
  • 79
    • 79959624262 scopus 로고    scopus 로고
    • Leukotriene receptors are differently expressed in fibroblast from peripheral versus central airways in asthmatics and healthy controls
    • Tufvesson E, Nihlberg K, Westergren-Thorsson G. Leukotriene receptors are differently expressed in fibroblast from peripheral versus central airways in asthmatics and healthy controls. Prostaglandins Leukot Essent Fatty Acids 2011;85:67-73
    • (2011) Prostaglandins Leukot Essent Fatty Acids , vol.85 , pp. 67-73
    • Tufvesson, E.1    Nihlberg, K.2    Westergren-Thorsson, G.3
  • 80
    • 39749151010 scopus 로고    scopus 로고
    • Montelukast inhibits inflammatory responses in small airways of the Guinea-pig
    • Harrison S, Gatti R, Baraldo S, et al. Montelukast inhibits inflammatory responses in small airways of the Guinea-pig. Pulm Pharmacol Ther 2008;21:317-23
    • (2008) Pulm Pharmacol Ther , vol.21 , pp. 317-323
    • Harrison, S.1    Gatti, R.2    Baraldo, S.3
  • 81
    • 84875209004 scopus 로고    scopus 로고
    • Effects of 24-week add-on treatment with ciclesonide and montelukast on small airways inflammation in asthma
    • Nakaji H, Petrova G, Matsumoto H, et al. Effects of 24-week add-on treatment with ciclesonide and montelukast on small airways inflammation in asthma. Ann Allergy Asthma Immunol 2013;110:198-203
    • (2013) Ann Allergy Asthma Immunol , vol.110 , pp. 198-203
    • Nakaji, H.1    Petrova, G.2    Matsumoto, H.3
  • 82
    • 84857918547 scopus 로고    scopus 로고
    • Impact of add-on pranlukast in stable asthma; The additive effect on peripheral airway inflammation
    • Yasui H, Fujisawa T, Inui N, et al. Impact of add-on pranlukast in stable asthma; the additive effect on peripheral airway inflammation. Respir Med 2012;106:508-14
    • (2012) Respir Med , vol.106 , pp. 508-514
    • Yasui, H.1    Fujisawa, T.2    Inui, N.3
  • 83
    • 0026606394 scopus 로고
    • Effects of treatment on airway inflammation and thickening of basement membrane reticular collagen in asthma
    • Jeffery PK, Godfrey E, Adelroth E, et al. Effects of treatment on airway inflammation and thickening of basement membrane reticular collagen in asthma. Am Rev Respir Dis 1992;145:890-9
    • (1992) Am Rev Respir Dis , vol.145 , pp. 890-899
    • Jeffery, P.K.1    Godfrey, E.2    Adelroth, E.3
  • 84
    • 0028240265 scopus 로고
    • Placebo-controlled immunopathologic study of four months of inhaled corticosteroids in asthma
    • Trigg CJ, Manolitsas ND, Wang J, et al. Placebo-controlled immunopathologic study of four months of inhaled corticosteroids in asthma. Am J Respir Crit Care Med 1994;150:17-22
    • (1994) Am J Respir Crit Care Med , vol.150 , pp. 17-22
    • Trigg, C.J.1    Manolitsas, N.D.2    Wang, J.3
  • 85
    • 0032938331 scopus 로고    scopus 로고
    • Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment
    • The AMPUL Study Group
    • Sont JK, Willems LN, Bel EH, et al. Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group. Am J Respir Crit Care Med 1999;159:1043-51
    • (1999) Am J Respir Crit Care Med , vol.159 , pp. 1043-1051
    • Sont, J.K.1    Willems, L.N.2    Bel, E.H.3
  • 86
    • 0033777542 scopus 로고    scopus 로고
    • Airway hyperresponsiveness, inflammation, and subepithelial collagen deposition in recently diagnosed versus long-standing mild asthma: Influence of inhaled corticosteroids
    • Boulet LP, Turcotte H, Laviolette M, et al. Airway hyperresponsiveness, inflammation, and subepithelial collagen deposition in recently diagnosed versus long-standing mild asthma: influence of inhaled corticosteroids. Am J Respir Crit Care Med 2000;162:1308-13
    • (2000) Am J Respir Crit Care Med , vol.162 , pp. 1308-1313
    • Boulet, L.P.1    Turcotte, H.2    Laviolette, M.3
  • 87
    • 0032845858 scopus 로고    scopus 로고
    • Inhaled corticosteroids decrease subepithelial collagen deposition by modulation of the balance between matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 expression in asthma
    • Hoshino M, Takahashi M, Takai Y, et al. Inhaled corticosteroids decrease subepithelial collagen deposition by modulation of the balance between matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 expression in asthma. J Allergy Clin Immunol 1999;104:356-63
    • (1999) J Allergy Clin Immunol , vol.104 , pp. 356-363
    • Hoshino, M.1    Takahashi, M.2    Takai, Y.3
  • 89
    • 33748860064 scopus 로고    scopus 로고
    • Montelukast treatment attenuates the increase in myofibroblasts following low-dose allergen challenge
    • Kelly MM, Chakir J, Vethanayagam D, et al. Montelukast treatment attenuates the increase in myofibroblasts following low-dose allergen challenge. Chest 2006;130:741-53
    • (2006) Chest , vol.130 , pp. 741-753
    • Kelly, M.M.1    Chakir, J.2    Vethanayagam, D.3
  • 90
    • 4444280860 scopus 로고    scopus 로고
    • Effects of anti-asthmatic agents on the functions of peripheral blood monocyte-derived dendritic cells from atopic patients
    • Saeki S, Matsuse H, Kondo Y, et al. Effects of anti-asthmatic agents on the functions of peripheral blood monocyte-derived dendritic cells from atopic patients. J Allergy Clin Immunol 2004;114:538-44
    • (2004) J Allergy Clin Immunol , vol.114 , pp. 538-544
    • Saeki, S.1    Matsuse, H.2    Kondo, Y.3
  • 91
    • 1642443955 scopus 로고    scopus 로고
    • Cysteinyl leukotrienes regulate dendritic cell functions in a murine model of asthma
    • Machida I, Matsuse H, Kondo Y, et al. Cysteinyl leukotrienes regulate dendritic cell functions in a murine model of asthma. J Immunol 2004;172:1833-8
    • (2004) J Immunol , vol.172 , pp. 1833-1838
    • Machida, I.1    Matsuse, H.2    Kondo, Y.3
  • 92
    • 22744454954 scopus 로고    scopus 로고
    • Effects of anti-asthmatic agents on mite allergen pulsed murine bone marrow-derived dendritic cells
    • Machida I, Matsuse H, Kondo Y, et al. Effects of anti-asthmatic agents on mite allergen pulsed murine bone marrow-derived dendritic cells. Clin Exp Allergy 2005;35:884-8
    • (2005) Clin Exp Allergy , vol.35 , pp. 884-888
    • Machida, I.1    Matsuse, H.2    Kondo, Y.3
  • 94
    • 2342525092 scopus 로고    scopus 로고
    • The position of pranlukast, a cysteinyl leukotriene receptor antagonist, in the long-term treatment of asthma. 5-year follow-up study
    • Obase Y, Shimoda T, Matsuse H, et al. The position of pranlukast, a cysteinyl leukotriene receptor antagonist, in the long-term treatment of asthma. 5-year follow-up study. Respiration 2004;71:225-32
    • (2004) Respiration , vol.71 , pp. 225-232
    • Obase, Y.1    Shimoda, T.2    Matsuse, H.3
  • 95
    • 33847288181 scopus 로고    scopus 로고
    • Safety of leukotriene receptor antagonists in pregnancy
    • Bakhireva LN, Jones KL, Schatz M, et al. Safety of leukotriene receptor antagonists in pregnancy. J Allergy Clin Immunol 2007;119:618-25
    • (2007) J Allergy Clin Immunol , vol.119 , pp. 618-625
    • Bakhireva, L.N.1    Jones, K.L.2    Schatz, M.3
  • 96
    • 75849157844 scopus 로고    scopus 로고
    • A randomized placebo-controlled study of intravenous montelukast for the treatment of acute asthma
    • Camargo CA Jr, Gurner DM, Smithline HA, et al. A randomized placebo-controlled study of intravenous montelukast for the treatment of acute asthma. J Allergy Clin Immunol 2010;125:374-80
    • (2010) J Allergy Clin Immunol , vol.125 , pp. 374-380
    • Camargo Jr., C.A.1    Gurner, D.M.2    Smithline, H.A.3
  • 97
    • 70249108874 scopus 로고    scopus 로고
    • Inhaled montelukast inhibits cysteinyl-leukotriene-induced bronchoconstriction in ovalbuminsensitized guinea-pigs: The potential as a new asthma medication
    • Muraki M, Imbe S, Sato R, et al. Inhaled montelukast inhibits cysteinyl-leukotriene-induced bronchoconstriction in ovalbuminsensitized guinea-pigs: the potential as a new asthma medication. Int Immunopharmacol 2009;9:1337-41
    • (2009) Int Immunopharmacol , vol.9 , pp. 1337-1341
    • Muraki, M.1    Imbe, S.2    Sato, R.3
  • 98
    • 79958168428 scopus 로고    scopus 로고
    • Effects of a cysteinyl leukotriene dual 1/2 receptor antagonist on antigen-induced airway hypersensitivity and airway inflammation in a guinea pig asthma model
    • Muraki M, Imbe S, Santo H, et al. Effects of a cysteinyl leukotriene dual 1/2 receptor antagonist on antigen-induced airway hypersensitivity and airway inflammation in a guinea pig asthma model. Int Arch Allergy Immunol 2011;155(Suppl 1):90-5
    • (2011) Int Arch Allergy Immunol , vol.155 , Issue.SUPPL. 1 , pp. 90-95
    • Muraki, M.1    Imbe, S.2    Santo, H.3
  • 99
    • 77952313992 scopus 로고    scopus 로고
    • Leukotriene A4 hydrolase inhibition attenuates allergic airway inflammation and hyperresponsiveness
    • Rao NL, Riley JP, Banie H, et al. Leukotriene A4 hydrolase inhibition attenuates allergic airway inflammation and hyperresponsiveness. Am J Respir Crit Care Med 2010;181:899-907
    • (2010) Am J Respir Crit Care Med , vol.181 , pp. 899-907
    • Rao, N.L.1    Riley, J.P.2    Banie, H.3
  • 100
    • 84883522991 scopus 로고    scopus 로고
    • Antileukotriene agents for the treatment of lung disease
    • A latest and concise summary of anti-LT agents
    • Scott JP, Peters-Golden M. Antileukotriene agents for the treatment of lung disease. Am J Respir Crit Care Med 2013;188:538-44. A latest and concise summary of anti-LT agents.
    • (2013) Am J Respir Crit Care Med , vol.188 , pp. 538-44
    • Scott, J.P.1    Peters-Golden, M.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.